Schedule 13D ownership disclosure
ACELYRIN INC
Common Stock, par value $0.00001 per share · CUSIP: 00445A100
Event date: 2025-05-21
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- TANG CAPITAL MANAGEMENT, LLCReported CIK 0001232621
Shares: 0.00 · Class: 0%
- KEVIN TANGReported CIK 0001178579
Shares: 0.00 · Class: 0%
- TANG CAPITAL PARTNERS, LPReported CIK 0001191935
Shares: 0.00 · Class: 0%
- TANG CAPITAL PARTNERS INTERNATIONAL, LPReported CIK 0002064011
Shares: 0.00 · Class: 0%
- TANG CAPITAL PARTNERS III, INCReported CIK 0002036763
Shares: 0.00 · Class: 0%
- TANG CAPITAL PARTNERS IV, INCReported CIK 0002036770
Shares: 0.00 · Class: 0%
- CONCENTRA BIOSCIENCES, LLCReported CIK 0001970065
Shares: 0.00 · Class: 0%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001214659-25-008304
- Form type
- SCHEDULE 13D/A
- Filer
- ACELYRIN, Inc.
- CIK
- CIK 1962918
- Filed
- May 23, 2025
- Reporting period
- May 21, 2025
- Description
- Schedule 13D beneficial ownership